Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | Jacob Catayoc |
|---|---|
| Location: | Pasay City, Metro Manila, Philippines |
| Users: | 5 |
| Nodes: | 4 (0 / 4) |
| Uptime: | 493843:32:58 |
| Calls: | 146 |
| Files: | 547 |
| D/L today: |
6 files (97K bytes) |
| Messages: | 76,650 |